Endure Biotherapeutics, Inc.

Carlsbad, CA

UEI
J63ZBR8YEXS2
CAGE
05R65
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
7704 Corte Violeta, Carlsbad, CA 92009, USA
Website
endurebio.com
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Endure Biotherapeutics, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase i: a novel precision microbiome therapy for phenylketonuria -the broader impact/commercial potential of… Grant · 2538091 National Science Foundation $305,000
Development of novel engineered native bacteria (ENB) for the treatment of familial adenomatous polyposis - project… Grant · R43CA291510 National Cancer Institute $392,827

Quick answers

What is Endure Biotherapeutics, Inc.'s UEI?

Endure Biotherapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is J63ZBR8YEXS2.

What is Endure Biotherapeutics, Inc.'s CAGE code?

Endure Biotherapeutics, Inc.'s CAGE code is 05R65.

What is Endure Biotherapeutics, Inc.'s primary NAICS code?

Endure Biotherapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Endure Biotherapeutics, Inc. located?

Endure Biotherapeutics, Inc.'s physical address in SAM.gov is 7704 Corte Violeta, Carlsbad, CA 92009, USA.

Is Endure Biotherapeutics, Inc. registered in SAM.gov?

Yes. Endure Biotherapeutics, Inc.'s SAM.gov registration is active through August 25, 2027.

What is Endure Biotherapeutics, Inc.'s most recent federal award?

Endure Biotherapeutics, Inc.'s most recent federal grant award is Sbir phase i: a novel precision microbiome therapy for phenylketonuria -the broader impact/commercial potential of… (2538091), from National Science Foundation, on July 1, 2026.

On GovTribe

See Endure Biotherapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login